XORTX Therapeutics (XRTX) Research & Development (2020 - 2026)
XORTX Therapeutics (XRTX) posted Research & Development of $33113.0 for Q1 2026, down 41.92% on a QoQ basis from $57011.0 in Q3 2025.
XORTX Therapeutics (XRTX) Research & Development (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Research & Development history runs 7 years deep, the most recent figure standing at $33113.0 for Q1 2026.
- Quarterly Research & Development changed N/A year-over-year to $33113.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (changed N/A YoY) and the FY2025 annual result came in at $411493.3, up 206.47% from the prior year.
- Research & Development was $33113.0 for Q1 2026 at XORTX Therapeutics, down from $57011.0 in the prior quarter.
- Across five years, Research & Development topped out at $1.5 million in Q1 2022 and bottomed at -$1.6 million in Q4 2023.
- A 5-year average of $494436.1 and a median of $497229.5 in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 13871.85% — and 2023, when it tumbled 212.66%.
- XORTX Therapeutics' Research & Development stood at $1.4 million in 2022, then tumbled by 212.66% to -$1.6 million in 2023, then soared by 102.2% to $34741.0 in 2024, then jumped by 64.1% to $57011.0 in 2025, then slumped by 41.92% to $33113.0 in 2026.
- Business Quant data shows XRTX's Research & Development at $33113.0 in Q1 2026, $57011.0 in Q3 2025, and $34741.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 33,113.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,113.00 |
| Sep 30, 2025 | 57,011.00 |
| Sep 30, 2024 | 34,741.00 |
| Dec 31, 2023 | -1.58 Mn |
| Sep 30, 2023 | 424,966.29 |
| Jun 30, 2023 | 497,229.48 |
| Mar 31, 2023 | 774,430.29 |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 341,886.60 |
| Sep 30, 2021 | 303,438.14 |
| Jun 30, 2021 | 26,423.00 |
| Mar 31, 2021 | 10,892.31 |
| Dec 31, 2020 | 109,342.11 |
| Sep 30, 2020 | 90,075.60 |